Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population‐based target trial in British Columbia, Canada

Compared with no urine drug testing, weekly urine drug testing may be associated with improved opioid agonist treatment retention; however, the high costs attributable to frequent testing may not be cost-effective and requires further evaluation. There was no improvement associated with less frequent testing compared with no monitoring.

Authors

Institutions

Publication Details

Journal
Addiction
Published
2025-08-31
DOI
https://doi.org/10.1111/add.70171
Citations
1
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
1.88

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population‐based target trial in British Columbia, Canada

Micah Piske, Paxton Bach, Sander Greenland, Uwe Siebert et al.
1 citations
Addiction
Opioid Use Disorder Treatment
1.88
article

Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population‐based target trial in British Columbia, Canada

Micah Piske, Paxton Bach, Sander Greenland, Uwe Siebert, Brenda Carolina Guerra‐Alejos, Kyle M. Kampman, Jeong Eun Min, P. Todd Korthuis, M. Eugenia Socías, Mohammad Ehsanul Karim, Paul Gustafson, Shaun R. Seaman, Evan Wood, Julie Bruneau, Bohdan Nosyk, Robert W. Platt, Megan Kurz
article en
1 citations

Abstract

Compared with no urine drug testing, weekly urine drug testing may be associated with improved opioid agonist treatment retention; however, the high costs attributable to frequent testing may not be cost-effective and requires further evaluation. There was no improvement associated with less frequent testing compared with no monitoring.

AddictionVol. 120(12)
University of British Columbia Hospital (CA), Harvard University (US), University of California, Los Angeles (US), Oregon Health & Science University (US), Simon Fraser University (CA), University of Cambridge (GB), UCLA Health (US), McGill University Health Centre (CA), Massachusetts General Hospital (US), British Columbia Centre on Substance Use (CA), UMIT - Private Universität für Gesundheitswissenschaften, Medizinische Informatik und Technik (AT), Center for Advancing Health (US), MRC Biostatistics Unit (GB), Institute of Population and Public Health (CA), Centre for Advancing Health Outcomes (CA), Centre Hospitalier de l’Université de Montréal (CA), McGill University (CA), Université de Montréal (CA), University of Pennsylvania (US)
National Institutes of Health, Health Canada, National Institute on Drug Abuse
Openalex Percentile: Top 12%
Opioid Use Disorder Treatment
1.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.